USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYING OF CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY

被引：0
|
作者：
Hu, J. [1 ]
Aprikian, A. [2 ]
Vanhuyse, M. [2 ]
Dragomir, A. [2 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.330
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN248
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [1] POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL HORMONAL AGENTS AT THE END-OF-LIFE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
    Hu, J.
    Aprikian, A.
    Vanhuyse, M.
    Dragomir, A.
    VALUE IN HEALTH, 2020, 23 : S63 - S63
  • [2] POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL HORMONAL AGENTS AT THE END-OF-LIFE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
    Hu, Jason
    Aprikian, Armen
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF UROLOGY, 2020, 203 : E1223 - E1223
  • [3] Population-based study on use of chemotherapy in men with castration resistant prostate cancer
    Lissbrant, Ingela Franck
    Garmo, Hans
    Widmark, Anders
    Stattin, Par
    ACTA ONCOLOGICA, 2013, 52 (08) : 1593 - 1601
  • [4] POPULATION-BASED ANALYSIS OF TREATMENT TOXICITY AMONG MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
    Nam, Robert
    Wallis, Christopher
    Saskin, Refik
    Bansal, Symron
    Emmenegger, Urban
    Satkunasivam, Raj
    JOURNAL OF UROLOGY, 2017, 197 (04): : E766 - E767
  • [5] Population-based analysis of treatment toxicity among men with castration-resistant prostate cancer
    Nam, Robert
    Wallis, Christopher J. D.
    Saskin, Refik
    Bansal, Symron
    Emmenegger, Urban
    Satkunasivam, Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Cancer Drug Use in the Last Month of Life in Men With Castration-Resistant Prostate Cancer
    Hu, Jason
    Aprikian, Armen G.
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (06) : 333 - +
  • [7] Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV Study
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    Saskin, Refik
    Bansal, Symron
    Kulkarni, Girish S.
    Emmenegger, Urban
    Nam, Robert K.
    UROLOGY, 2018, 113 : 138 - 144
  • [8] Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based study
    Malone, Shawn
    Wallis, Christopher J. D.
    Lee-Ying, Richard
    Basappa, Naveen S.
    Cagiannos, Ilias
    Hamilton, Robert J.
    Fernandes, Ricardo
    Ferrario, Cristiano
    Gotto, Geoffrey T.
    Morgan, Scott C.
    Morash, Christopher
    Niazi, Tamim
    Noonan, Krista L.
    Rendon, Ricardo
    Hotte, Sebastien J.
    Saad, Fred
    Zardan, Anousheh
    Osborne, Brendan
    Chan, Katherine F. Y.
    Shayegan, Bobby
    BJUI COMPASS, 2022, 3 (05): : 383 - 391
  • [9] Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
    Aly, Markus
    Leval, Amy
    Schain, Frida
    Liwing, Johan
    Lawson, Joe
    Vago, Emese
    Nordstrom, Tobias
    Andersson, Therese M. -L.
    Sjoland, Erik
    Wang, Chen
    Eloranta, Sandra
    Akre, Olof
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (02) : 115 - 121
  • [10] COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Alemayehu, B.
    Parry, D.
    Engel-Nitz, N. M.
    Kulakodlu, M.
    Nathan, F.
    VALUE IN HEALTH, 2011, 14 (03) : A161 - A162
12345